Saturday, May 3, 2014
Medical Professionals and Industry Insiders Are Needed To Expose Fraud in the Spinal Stimulator Industry by Spinal Stimulator Off Label Whistleblower Lawyer
Implantable Spinal-Devices Are a Multi-billion Dollar Industry and the Leaders In the Industry Are Medtronic, St. Jude Medical, and Boston Scientific by Spinal Stimulator Off Label Use Whistleblower Lawyer
Implantable Neurostimulation Systems and other spinal-devices are a huge business for the medical implant device industry. The global market for spinal-devices is currently over $ 3 billion per year and is expected to increase to over $5 billion per year by 2018. Currently, the major manufacturers in the neurostimulator market are Medtronic, St. Jude Medical, and Boston Scientific.
Neurostimulators have been used for a variety of types of chronic back pain situations including heriniated disks, postlaminectomy paid, Complex Reginal Pay Syndrome, unsuccessful disk surgery, Degenerative Disk Disease, and Failed Back Syndrome. The Medtronic implantable neurostimulation system is indicated for spinal cord stimulation (SCS) as an aid in the management of chronic, intractable pain of the trunk and/or limbs—including unilateral or bilateral pain associated with several different conditions. Unfortunately, because of the profits to be made from implanting a spinal stimulator, many people have received spinal stimulators for off-label or non-approved indications.
Medical professionals that are aware of significant off-label use of spinal stimulators are encouraged to properly report any Medicare fraud or Medicaid fraud that may be occurring. Further, through a whistleblower qui tam action, these whistleblowers can receive large financial rewards for being the first to expose Medicare fraud or Medicaid fraud. Please feel free to go to the following web page for information on Qui Tam Whistleblower Reward Lawsuits and Reporting Medicare Fraud.